Long-term effects of anti-TNF therapy on bone metabolism

被引:0
|
作者
O'Morain, N. [1 ]
Farrell, G. [1 ]
Hanly, M. [1 ]
Veerappan, S. [1 ]
McNamara, D. [1 ,2 ]
Breslin, N. [1 ]
O'Morain, C. [2 ]
Healy, M. [3 ]
Ryan, B. [1 ,2 ]
机构
[1] Tallaght Hosp, Gastroenterol, Dublin, Ireland
[2] Trinity Coll Dublin, Dublin, Ireland
[3] St James Hosp, Dublin, Ireland
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P463
引用
收藏
页码:S339 / S339
页数:1
相关论文
共 50 条
  • [21] Long-term anti-TNFα therapy for ankylosing spondylitis in two patients with chronic HBV infection
    Sakellariou, Grigorios T.
    Chatzigiannis, Ioannis
    CLINICAL RHEUMATOLOGY, 2007, 26 (06) : 950 - 952
  • [22] Long-Term Outcome of IBD Patients With Primary Non-Response to Anti-TNF Therapy
    Papamichael, Konstantinos
    Rivals, Oliviane
    Billiet, Thomas
    Ferrante, Marc
    Van Assche, Gert A.
    Rutgeerts, Paul J.
    Mantzaris, Gerassimos J.
    Peyrin-Biroulet, Laurent
    Vermeire, Severine
    GASTROENTEROLOGY, 2015, 148 (04) : S864 - S864
  • [23] EVALUATION OF BONE METABOLISM DURING ANTI-TNF THERAPY IN INFLAMMATORY BOWEL DISEASES
    Petruzzellis, C.
    Sparano, L.
    Cesari, P.
    Boselli, C.
    Pagani, F.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E194 - E194
  • [24] Influence of anti-TNF therapy on bone metabolism in patients with inflammatory bowel disease
    Castro, Beatriz
    Rivero, Montserrat
    Crespo, Javier
    Antonio Riancho, J.
    Valero, Carmen
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 39 : E33 - E34
  • [25] Long-term treatment of refractory posterior uveitis with anti-TNFα (infliximab)
    Benitez-del-Castillo, JM
    Martinez-de-la-Casa, JM
    Pato-Cour, E
    Méndez-Fernández, R
    López-Abad, C
    Matilla, M
    Garcia-Sanchez, J
    EYE, 2005, 19 (08) : 841 - 845
  • [26] Long-term treatment of refractory posterior uveitis with anti-TNFα (infliximab)
    J M Benitez-del-Castillo
    J M Martinez-de-la-Casa
    E Pato-Cour
    R Méndez-Fernández
    C López-Abad
    M Matilla
    J Garcia-Sanchez
    Eye, 2005, 19 : 841 - 845
  • [27] Monitoring of cell-mediated immunity parameters in RA patients on long-term anti-TNF therapy
    Blazickova, S
    Lackovic, V
    Mateicka, F
    Poprac, P
    Rovensky, J
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 128 - 129
  • [28] OUTCOMES OF LONG-TERM ANTI-TNF THERAPY BEYOND 10 YEARS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Dicken, Quinten
    Ananthakrishnan, Ashwin
    GASTROENTEROLOGY, 2024, 166 (05) : S1132 - S1132
  • [29] EFFECTS OF ANTI-TNF AGENTS ON BONE DENSITY AND MARKERS OF BONE METABOLISM IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Malaiya, Ritu
    Rachapalli, Satish M.
    RHEUMATOLOGY, 2010, 49 : I91 - I91
  • [30] Long-term anti-TNF therapy safety outcomes - results from biology therapy register of JIA patients in Slovakia
    Vargova, V.
    Koskova, E.
    Rovensky, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 402 - 402